|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.47 CNY | +0.72% |
|
+1.15% | +0.65% |
| Capitalization | 24.23B 3.48B 2.99B 2.77B 2.59B 4.82B 316B 5.18B 32.04B 12.62B 151B 13.05B 12.78B 550B | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 13.24B 1.9B 1.63B 1.51B 1.42B 2.63B 173B 2.83B 17.5B 6.89B 82.24B 7.13B 6.98B 301B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
37.52% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
| 1 day | +0.72% | ||
| 1 week | +1.15% | ||
| Current month | +0.65% | ||
| 1 month | -0.90% | ||
| 3 months | +4.79% | ||
| 6 months | -4.09% | ||
| Current year | +0.65% |
| 1 week | 25.83 |  | 26.63 |
| 1 month | 25.83 | | 27.03 |
| Current year | 25.83 | | 26.71 |
| 1 year | 24.2 | | 30.39 |
| 3 years | 23.85 | | 45.18 |
| 5 years | 14.37 | | 45.18 |
| 10 years | 14.37 | | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 43 | 2019-12-19 |
Hong Cun Yan
DFI | Director of Finance/CFO | 58 | 2022-09-25 |
Wei Cao
SEC | Corporate Secretary | 40 | 2018-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Long Xiang Cao
CHM | Chairman | 69 | 2014-03-09 |
Qu Rong Huang
BRD | Director/Board Member | 64 | 2014-03-09 |
Fei Cao
BRD | Director/Board Member | 43 | 2014-03-09 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -19.71% | 0.42% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.72% | +1.15% | -5.97% | -6.70% | 3.47B | |
| +0.64% | -3.58% | -15.94% | -31.90% | 6.12B | |
| -0.20% | -1.64% | -21.78% | +17.71% | 4.53B | |
| +0.46% | -3.93% | +51.42% | +48.28% | 4.38B | |
| -0.96% | -2.01% | +11.43% | -39.04% | 4.21B | |
| +0.33% | -1.37% | +6.26% | +31.99% | 3.23B | |
| +2.00% | +1.51% | +9.78% | -19.40% | 2.5B | |
| -0.33% | -0.69% | +16.43% | +4.23% | 1.99B | |
| -0.29% | -1.88% | -1.56% | +50.76% | 1.69B | |
| -0.41% | +2.47% | +13.10% | +61.85% | 1.69B | |
| Average | +0.20% | -0.75% | +6.32% | +11.78% | 3.38B | |
| Weighted average by Cap. | +0.23% | -1.18% | +4.54% | +4.82% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 1.55B 222M 191M 177M 165M 308M 20.19B 331M 2.05B 806M 9.61B 833M 816M 35.12B | 1.72B 248M 213M 197M 184M 343M 22.5B 369M 2.28B 898M 10.71B 928M 909M 39.14B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
5,026
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-18 | 26.47 ¥ | +0.72% | 4,148,719 |
| 26-01-16 | 26.28 ¥ | -0.90% | 4,154,227 |
| 26-01-15 | 26.52 ¥ | +1.57% | 5,901,602 |
| 26-01-14 | 26.11 ¥ | +0.12% | 5,040,241 |
| 26-01-13 | 26.08 ¥ | 0.00% | 4,053,017 |
End-of-day quote Shanghai S.E., January 18, 2026
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
26.47
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600566 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition